Epidemiologic evidence for a role of telomere dysfunction in cancer etiology

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 730, Issue 1-2, 2012, Pages 75-84

  Prescott, Jennifer ^a,b   Wentzensen, Ingrid M ^c   Savage, Sharon A ^c   De Vivo, Immaculata ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Epidemiology; Telomere length

Indexed keywords

CELL DNA; TELOMERASE;

BASAL CELL CARCINOMA; BLADDER CANCER; BREAST CANCER; CANCER RISK; CANCER TISSUE; CARCINOGENESIS; CELL AGING; CELL DIVISION; CELLULAR SENSCENCE; COLORECTAL CANCER; DNA REPAIR; DNA REPLICATION; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; ETHNIC GROUP; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMIC INSTABILITY; HEAD AND NECK CANCER; HUMAN; KIDNEY CARCINOMA; LUNG CANCER; MALIGNANT TRANSFORMATION; MENTAL STRESS; NONHODGKIN LYMPHOMA; OVARY CANCER; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SKIN CANCER; STOMACH CANCER; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING;

CELL AGING; CELL TRANSFORMATION, NEOPLASTIC; EPIDEMIOLOGIC METHODS; GENOMIC INSTABILITY; HUMANS; NEOPLASMS; RESEARCH DESIGN; RISK ASSESSMENT; TELOMERE; TELOMERE SHORTENING;

EID: 84855485056     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.06.009     Document Type: Review

References (76)

1. Stewart S.A., Weinberg R.A. Telomeres: cancer to human aging. Annu. Rev. Cell Dev. Biol. 2006, 22:531-557.
2. Palm W., de Lange T. How shelterin protects mammalian telomeres. Annu. Rev. Genet. 2008, 42:301-334.
3. Olovnikov A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 1973, 41:181-190.
4. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., Futcher A.B., Greider C.W., Harley C.B. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:10114-10118.
5. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 2002, 27:339-344.
6. Houben J.M., Moonen H.J., van Schooten F.J., Hageman G.J. Telomere length assessment: biomarker of chronic oxidative stress?. Free Radic. Biol. Med. 2008, 44:235-246.
7. Nawrot T.S., Staessen J.A., Gardner J.P., Aviv A. Telomere length and possible link to X chromosome. Lancet 2004, 363:507-510.
8. Garcia C.K., Wright W.E., Shay J.W. Human diseases of telomerase dysfunction: insights into tissue aging. Nucleic Acids Res. 2007, 35:7406-7416.
9. Valdes A.M., Andrew T., Gardner J.P., Kimura M., Oelsner E., Cherkas L.F., Aviv A., Spector T.D. Obesity, cigarette smoking, and telomere length in women. Lancet 2005, 366:662-664.
10. Prescott J., McGrath M., Lee I.M., Buring J.E., De Vivo I. Telomere length and genetic analyses in population-based studies of endometrial cancer risk. Cancer 2010, 4275-4282.
11. Nordfjall K., Eliasson M., Stegmayr B., Melander O., Nilsson P., Roos G. Telomere length is associated with obesity parameters but with a gender difference. Obesity (Silver Spring) 2008, 16:2682-2689.
12. Cherkas L.F., Hunkin J.L., Kato B.S., Richards J.B., Gardner J.P., Surdulescu G.L., Kimura M., Lu X., Spector T.D., Aviv A. The association between physical activity in leisure time and leukocyte telomere length. Arch. Intern. Med. 2008, 168:154-158.
13. Kim S., Parks C.G., DeRoo L.A., Chen H., Taylor J.A., Cawthon R.M., Sandler D.P. Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol. Biomark. Prev. 2009, 18:816-820.
14. Nettleton J.A., Diez-Roux A., Jenny N.S., Fitzpatrick A.L., Jacobs D.R. Dietary patterns, food groups, and telomere length in the Multi-Ethnic Study of Atherosclerosis (MESA). Am. J. Clin. Nutr. 2008, 88:1405-1412.
15. Mirabello L., Huang W.Y., Wong J.Y., Chatterjee N., Reding D., Crawford E.D., De Vivo I., Hayes R.B., Savage S.A. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell 2009, 8:405-413.
16. Aviv A. Telomeres and human somatic fitness. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61:871-873.
17. Blackburn E.H. Telomere states and cell fates. Nature 2000, 408:53-56.
18. d'Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat. Rev. Cancer 2008, 8:512-522.
19. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 2001, 11:S27-S31.
20. Campisi J., Kim S.H., Lim C.S., Rubio M. Cellular senescence, cancer and aging: the telomere connection. Exp. Gerontol. 2001, 36:1619-1637.
21. van Heek N.T, Meeker A.K., Kern S.E., Yeo C.J., Lillemoe K.D., Cameron J.L., Offerhaus G.J., Hicks J.L., Wilentz R.E., Goggins M.G., De Marzo A.M., Hruban R.H., Maitra A. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am. J. Pathol. 2002, 161:1541-1547.
22. Meeker A.K., Hicks J.L., Platz E.A., March G.E., Bennett C.J., Delannoy M.J., De Marzo A.M. Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res. 2002, 62:6405-6409.
23. Kawai T., Hiroi S., Nakanishi K., Meeker A.K. Telomere length and telomerase expression in atypical adenomatous hyperplasia and small bronchioloalveolar carcinoma of the lung. Am. J. Clin. Pathol. 2007, 127:254-262.
24. Meeker A.K., Hicks J.L., Iacobuzio-Donahue C.A., Montgomery E.A., Westra W.H., Chan T.Y., Ronnett B.M., De Marzo A.M. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin. Cancer Res. 2004, 10:3317-3326.
25. Chin K., de Solorzano C.O., Knowles D., Jones A., Chou W., Rodriguez E.G., Kuo W.L., Ljung B.M., Chew K., Myambo K., Miranda M., Krig S., Garbe J., Stampfer M., Yaswen P., Gray J.W., Lockett S.J. In situ analyses of genome instability in breast cancer. Nat. Genet. 2004, 36:984-988.
26. Hansel D.E., Meeker A.K., Hicks J., De Marzo A.M., Lillemoe K.D., Schulick R., Hruban R.H., Maitra A., Argani P. Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma. Mod. Pathol. 2006, 19:772-779.
27. Breslow N.E, Day N.E. Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci. Publ. 1980, 5-338.
28. Ehrlenbach S., Willeit P., Kiechl S., Willeit J., Reindl M., Schanda K., Kronenberg F., Brandstatter A. Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay. Int. J. Epidemiol. 2009, 38:1725-1734.
29. Breslow N.E., Day N.E. Statistical methods in cancer research. Volume II - The design and analysis of cohort studies. IARC Sci. Publ. 1987, 1-406.
30. Youngren K., Jeanclos E., Aviv H., Kimura M., Stock J., Hanna M., Skurnick J., Bardeguez A., Aviv A. Synchrony in telomere length of the human fetus. Hum. Genet. 1998, 102:640-643.
31. Okuda K., Bardeguez A., Gardner J.P., Rodriguez P., Ganesh V., Kimura M., Skurnick J., Awad G., Aviv A. Telomere length in the newborn. Pediatr. Res. 2002, 52:377-381.
32. Butler M.G., Tilburt J., DeVries A., Muralidhar B., Aue G., Hedges L., Atkinson J., Schwartz H. Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages. Cancer Genet. Cytogenet. 1998, 105:138-144.
33. Friedrich U., Griese E., Schwab M., Fritz P., Thon K., Klotz U. Telomere length in different tissues of elderly patients. Mech. Ageing Dev. 2000, 119:89-99.
34. Martens U.M., Zijlmans J.M., Poon S.S., Dragowska W., Yui J., Chavez E.A., Ward R.K., Lansdorp P.M. Short telomeres on human chromosome 17p. Nat. Genet. 1998, 18:76-80.
35. Wu X., Amos C.I., Zhu Y., Zhao H., Grossman B.H., Shay J.W., Luo S., Hong W.K., Spitz M.R. Telomere dysfunction: a potential cancer predisposition factor. J. Natl. Cancer Inst. 2003, 95:1211-1218.
36. Broberg K., Bjork J., Paulsson K., Hoglund M., Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005, 26:1263-1271.
37. McGrath M., Wong J.Y., Michaud D., Hunter D.J., De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol. Biomark. Prev. 2007, 16:815-819.
38. Levy T., Agoulnik I., Atkinson E.N., Tong X.W., Gause H.M., Hasenburg A., Runnebaum I.B., Stickeler E., Mobus V.J., Kaplan A.L., Kieback D.G. Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients. Anticancer Res. 1998, 18:1345-1349.
39. Barwell J., Pangon L., Georgiou A., Docherty Z., Kesterton I., Ball J., Camplejohn R., Berg J., Aviv A., Gardner J., Kato B.S., Carter N., Paximadas D., Spector T.D., Hodgson S. Is telomere length in peripheral blood lymphocytes correlated with cancer susceptibility or radiosensitivity?. Br. J. Cancer 2007, 97:1696-1700.
40. Shen J., Terry M.B., Gurvich I., Liao Y., Senie R.T., Santella R.M. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res. 2007, 67:5538-5544.
41. Svenson U., Nordfjall K., Stegmayr B., Manjer J., Nilsson P., Tavelin B., Henriksson R., Lenner P., Roos G. Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res. 2008, 68:3618-3623.
42. Shen J., Gammon M.D., Terry M.B., Wang Q., Bradshaw P., Teitelbaum S.L., Neugut A.I., Santella R.M. Telomere length, oxidative damage, antioxidants and breast cancer risk. Int. J. Cancer 2009, 124:1637-1643.
43. Zheng Y.L, Ambrosone C., Byrne C., Davis W., Nesline M., McCann S.E. Telomere length in blood cells and breast cancer risk: investigations in two case-control studies. Breast Cancer Res. Treat. 2010, 120:769-775.
44. Pooley K.A., Sandhu M.S., Tyrer J., Shah M., Driver K.E., Luben R.N., Bingham S.A., Ponder B.A., Pharoah P.D., Khaw K.T., Easton D.F., Dunning A.M. Telomere length in prospective and retrospective cancer case-control studies. Cancer Res. 2010, 70:3170-3176.
45. Gramatges M.M., Telli M.L., Balise R., Ford J.M. Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol. Biomark. Prev. 2010, 19:605-613.
46. Xing J., Ajani J.A., Chen M., Izzo J., Lin J., Chen Z., Gu J., Wu X. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev. Res. (Phila) 2009, 2:459-465.
47. Hou L., Savage S.A., Blaser M.J., Perez-Perez G., Hoxha M., Dioni L., Pegoraro V., Dong L.M., Zatonski W., Lissowska J., Chow W.H., Baccarelli A. Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol. Biomark. Prev. 2009, 18:3103-3109.
48. Liu X., Bao G., Huo T., Wang Z., He X., Dong G. Constitutive telomere length and gastric cancer risk: case-control analysis in Chinese Han population. Cancer Sci. 2009, 100:1300-1305.
49. Unryn B.M., Hao D., Gluck S., Riabowol K.T. Acceleration of telomere loss by chemotherapy is greater in older patients with locally advanced head and neck cancer. Clin. Cancer Res. 2006, 12:6345-6350.
50. Hosgood H.D., Cawthon R., He X., Chanock S., Lan Q. Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. Lung Cancer 2009, 66:157-161.
51. Jang J.S, Choi Y.Y., Lee W.K., Choi J.E., Cha S.I., Kim Y.J., Kim C.H., Kam S., Jung T.H., Park J.Y. Telomere length and the risk of lung cancer. Cancer Sci. 2008, 99:1385-1389.
52. Widmann T.A., Herrmann M., Taha N., Konig J., Pfreundschuh M. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Exp. Hematol. 2007, 35:939-946.
53. Mirabello L., Garcia-Closas M., Cawthon R., Lissowska J., Brinton L.A., Peplonska B., Sherman M.E., Savage S.A. Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control 2010, 21:77-82.
54. Cawthon R.M. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 2009, 37:e21.
55. Shao L., Wood C.G., Zhang D., Tannir N.M., Matin S., Dinney C.P., Wu X. Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J. Urol. 2007, 178:1492-1496.
56. De Vivo I., Prescott J., Wong J.Y., Kraft P., Hankinson S.E., Hunter D.J. A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol. Biomark. Prev. 2009, 18:1152-1156.
57. Lee I.M., Lin J., Castonguay A.J., Barton N.S., Buring J.E., Zee R.Y. Mean leukocyte telomere length and risk of incident colorectal carcinoma in women: a prospective, nested case-control study. Clin. Chem. Lab. Med. 2010, 48:259-262.
58. Zee R.Y, Castonguay A.J., Barton N.S., Buring J.E. Mean telomere length and risk of incident colorectal carcinoma: a prospective, nested case-control approach. Cancer Epidemiol. Biomark. Prev. 2009, 18:2280-2282.
59. Risques R.A., Vaughan T.L., Li X., Odze R.D., Blount P.L., Ayub K., Gallaher J.L., Reid B.J., Rabinovitch P.S. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol. Biomark. Prev. 2007, 16:2649-2655.
60. Lan Q., Cawthon R., Shen M., Weinstein S.J., Virtamo J., Lim U., Hosgood H.D., Albanes D., Rothman N. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin. Cancer Res. 2009, 15:7429-7433.
61. Han J., Qureshi A.A., Prescott J., Guo Q., Ye L., Hunter D.J., De Vivo I. A prospective study of telomere length and the risk of skin cancer. J. Invest. Dermatol. 2009, 129:415-421.
62. Rafnar T., Sulem P., Stacey S.N., Geller F., Gudmundsson J., Sigurdsson A., Jakobsdottir M., Helgadottir H., Thorlacius S., Aben K.K., Blondal T., Thorgeirsson T.E., Thorleifsson G., Kristjansson K., Thorisdottir K., Ragnarsson R., Sigurgeirsson B., Skuladottir H., Gudbjartsson T., Isaksson H.J., Einarsson G.V., Benediktsdottir K.R., Agnarsson B.A., Olafsson K., Salvarsdottir A., Bjarnason H., Asgeirsdottir M., Kristinsson K.T., Matthiasdottir S., Sveinsdottir S.G., Polidoro S., Hoiom V., Botella-Estrada R., Hemminki K., Rudnai P., Bishop D.T., Campagna M., Kellen E., Zeegers M.P., de Verdier P., Ferrer A., Isla D., Vidal M.J., Andres R., Saez B., Juberias P., Banzo J., Navarrete S., Tres A., Kan D., Lindblom A., Gurzau E., Koppova K., de Vegt F., Schalken J.A., van der Heijden H.F., Smit H.J., Termeer R.A., Oosterwijk E., van Hooij O., Nagore E., Porru S., Steineck G., Hansson J., Buntinx F., Catalona W.J., Matullo G., Vineis P., Kiltie A.E., Mayordomo J.I., Kumar R., Kiemeney L.A., Frigge M.L., Jonsson T., Saemundsson H., Barkardottir R.B., Jonsson E., Jonsson S., Olafsson J.H., Gulcher J.R., Masson G., Gudbjartsson D.F., Kong A., Thorsteinsdottir U., Stefansson K. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat. Genet. 2009, 41:221-227.
63. Willeit P., Willeit J., Mayr A., Weger S., Oberhollenzer F., Brandstatter A., Kronenberg F., Kiechl S. Telomere length and risk of incident cancer and cancer mortality. JAMA 2010, 304:69-75.
64. Michaloglou C., Vredeveld L.C., Soengas M.S., Denoyelle C., Kuilman T., van der Horst C.M., Majoor D.M., Shay J.W., Mooi W.J., Peeper D.S. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005, 436:720-724.
65. Gray-Schopfer V.C., Cheong S.C., Chong H., Chow J., Moss T., Abdel-Malek Z.A., Marais R., Wynford-Thomas D., Bennett D.C. Cellular senescence in naevi and immortalisation in melanoma: a role for p16?. Br. J. Cancer 2006, 95:496-505.
66. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J. Clin. 2010, 60:277-300.
67. Duensing A., Duensing S. Centrosomes, polyploidy and cancer. Adv. Exp. Med. Biol. 2010, 676:93-103.
68. Cawthon R.M Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002, 30:e47.
69. Grabowski P., Hultdin M., Karlsson K., Tobin G., Aleskog A., Thunberg U., Laurell A., Sundstrom C., Rosenquist R., Roos G. Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status. Blood 2005, 105:4807-4812.
70. Epel E.S., Blackburn E.H., Lin J., Dhabhar F.S., Adler N.E., Morrow J.D., Cawthon R.M. Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:17312-17315.
71. Parks C.G., Miller D.B., McCanlies E.C., Cawthon R.M., Andrew M.E., DeRoo L.A., Sandler D.P. Telomere length, current perceived stress, and urinary stress hormones in women. Cancer Epidemiol. Biomark. Prev. 2009, 18:551-560.
72. Tyrka A.R, Price L.H., Kao H.T., Porton B., Marsella S.A., Carpenter L.L. Childhood maltreatment and telomere shortening: preliminary support for an effect of early stress on cellular aging. Biol. Psychiatry 2010, 67:531-534.
73. Parker S.L., Davis K.J., Wingo P.A., Ries L.A., Heath C.W. Cancer statistics by race and ethnicity. CA Cancer J. Clin. 1998, 48:31-48.
74. Hunt S.C., Chen W., Gardner J.P., Kimura M., Srinivasan S.R., Eckfeldt J.H., Berenson G.S., Aviv A. Leukocyte telomeres are longer in African Americans than in whites: the National Heart, Lung, and Blood Institute Family Heart Study and the Bogalusa Heart Study. Aging Cell 2008, 7:451-458.
75. Roux A.V, Ranjit N., Jenny N.S., Shea S., Cushman M., Fitzpatrick A., Seeman T. Race/ethnicity and telomere length in the multi-ethnic study of atherosclerosis. Aging Cell 2009, 8:251-257.
76. Aviv A., Chen W., Gardner J.P., Kimura M., Brimacombe M., Cao X., Srinivasan S.R., Berenson G.S. Leukocyte telomere dynamics: longitudinal findings among young adults in the Bogalusa Heart Study. Am. J. Epidemiol. 2009, 169:323-329.